Holen Sie sich die Stockscreener-App
11.07
260.59%
8.00
Schlusskurs vom Vortag:
$3.07
Offen:
$10.145
24-Stunden-Volumen:
49.73M
Relative Volume:
81.32
Marktkapitalisierung:
$5.35M
Einnahmen:
$9.26M
Nettoeinkommen (Verlust:
$-941.60K
KGV:
-153.75
EPS:
-0.072
Netto-Cashflow:
$-2.65M
1W Leistung:
+314.61%
1M Leistung:
+158.04%
6M Leistung:
+295.78%
1J Leistung:
+135.53%
1-Tages-Spanne:
$8.83
$15.60
1-Wochen-Bereich:
$2.60
$15.60
52-Wochen-Spanne:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Firmenname
Bionexus Gene Lab Corp
Sektor
Branche
Telefon
1-307-241-6898
Adresse
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Vergleichen Sie BGLC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.35 | 544.73M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.43 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1427 | 316.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
2.64 | 118.42M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
1.72 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten
BioNexus Gene Lab Corp Regains Nasdaq Compliance With $1.00 Minimum Bid Price - marketscreener.com
Bionexus Gene Lab regains Nasdaq compliance - TipRanks
BioNexus Gene Lab regains Nasdaq compliance By Investing.com - Investing.com India
BioNexus Gene Lab regains Nasdaq compliance - Investing.com
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness - The Manila Times
BioNexus Gene Lab Corp. Regains Compliance with Nasdaq Listing Rule and Enhances Growth Strategy - Nasdaq
BioNexus Gene Lab Corp SEC 10-K Report - TradingView
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory - The Manila Times
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational - Bluefield Daily Telegraph
BioNexus Slashes Losses by 39%: Inside the Biotech's Strategic Pivot to Blockchain and AI - Stock Titan
3 Penny Stocks to Watch Now, 4/15/25 - TipRanks
12 Industrials Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Industrials Stocks Moving In Friday's Intraday Session - Benzinga
BioNexus Gene Lab Corp: Surge Insights - timothysykes.com
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Why BioNexus Gene Stock Jumps 55% in Premarket Trading - Own Snap
BioNexus Gene Lab enacts reverse stock split - Investing.com
BioNexus Gene Lab enacts reverse stock split By Investing.com - Investing.com India
BGLC stock touches 52-week high of $2.35 amid market fluctuations - Investing.com Australia
BGLC stock touches 52-week high of $2.35 amid market fluctuations By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Thursday's Intraday Session - Benzinga
BioNexus Gene Lab announces reverse stock split - Investing.com Australia
BioNexus Gene Lab announces reverse stock split By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Monday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Friday's After-Market Session - Benzinga
Bionexus Gene Lab enters partnership with ML Tech - Yahoo Finance
BioNexus Gene Lab Taps ML Tech for AI-Driven Ethereum Growth - tokenpost.com
BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy - The Manila Times
Continued Unit Revenue Growth - The Manila Times
BioNexus Gene Lab partners with ML Tech to optimize Ethereum growth strategies - Investing.com
Can AI Transform Corporate Ethereum Management? BioNexus Thinks So - StockTitan
Full Stock Market News from 2025-03-07 - StockTitan
BioNexus Pivots Ethereum as Primary Treasury Asset - Tekedia
Ethereum price forecast: Liquidity conditions to dictate direction amid sour sentiment - TU News
@0x1Tax - Binance
Bionexus Gene Lab Corp Makes History With Ethereum-Focused Treasury Strategy - Binance
Ethereum ETF Flows Fluctuate as Market Uncertainty Continues - The Currency Analytics
BioNexus Gene Lab Becomes First Nasdaq-Listed Firm to Prioritize Ethereum in Treasury Strategy - idfspokesperson.com
This Nasdaq company chooses Ethereum as a strategic reserve - Passionategeekz
Ethereum addresses containing more than 10,000 ETH decline significantly - TU News
WLFI boosts $10 million in ETH and $10 million in Wrapped Bitcoin for week - TU News
BioNexus Gene Lab becomes first public company with Ethereum reserves - Traders Union
Bionexus Gene Lab becomes the first Nasdaq-Genter company that embraces Ethereum as Treasury Asset - Passionategeekz
BioNexus Gene Lab Becomes First Nasdaq-Listed Company to Embrace Ethereum as Treasury Asset - BeInCrypto
Ethereum ETF flows fluctuate – What’s next for ETH? - AMBCrypto News
PA Daily | Trump family project WLFI increases holdings of ETH, WBTC and MOVE; BTC whale with a cost price of nearly $10,000 is suspected of selling BTC - PANews
Medical Tech Firm BioNexus Gene Lab Announces New Ethereum-Focused Treasury Strategy - Cryptonews
BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq To Do So - MSN
Finanzdaten der Bionexus Gene Lab Corp-Aktie (BGLC)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):